Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis
- PMID: 39231480
- PMCID: PMC11464399
- DOI: 10.1038/s41586-024-07993-x
Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis
Abstract
Hyperlipidaemia is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Risk of cardiovascular events depends on cumulative lifetime exposure to low-density lipoprotein cholesterol (LDL-C) and, independently, on the time course of exposure to LDL-C, with early exposure being associated with a higher risk1. Furthermore, LDL-C fluctuations are associated with ASCVD outcomes2-4. However, the precise mechanisms behind this increased ASCVD risk are not understood. Here we find that early intermittent feeding of mice on a high-cholesterol Western-type diet (WD) accelerates atherosclerosis compared with late continuous exposure to the WD, despite similar cumulative circulating LDL-C levels. We find that early intermittent hyperlipidaemia alters the number and homeostatic phenotype of resident-like arterial macrophages. Macrophage genes with altered expression are enriched for genes linked to human ASCVD in genome-wide association studies. We show that LYVE1+ resident macrophages are atheroprotective, and identify biological pathways related to actin filament organization, of which alteration accelerates atherosclerosis. Using the Young Finns Study, we show that exposure to cholesterol early in life is significantly associated with the incidence and size of carotid atherosclerotic plaques in mid-adulthood. In summary, our results identify early intermittent exposure to cholesterol as a strong determinant of accelerated atherosclerosis, highlighting the importance of optimal control of hyperlipidaemia early in life, and providing insights into the underlying biological mechanisms. This knowledge will be essential to designing effective therapeutic strategies to combat ASCVD.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures














Comment in
-
Lower your cholesterol early, and stick with it!Nat Rev Cardiol. 2025 Feb;22(2):69-70. doi: 10.1038/s41569-024-01095-x. Nat Rev Cardiol. 2025. PMID: 39424909 No abstract available.
Similar articles
-
ApoE Receptor-2 R952Q Variant in Macrophages Elevates Soluble LRP1 to Potentiate Hyperlipidemia and Accelerate Atherosclerosis in Mice.Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):37-48. doi: 10.1161/ATVBAHA.124.321748. Epub 2024 Nov 7. Arterioscler Thromb Vasc Biol. 2025. PMID: 39508104
-
Hepatic Expression of Niemann-Pick C1-Like 1, a Cholesterol Reabsorber from Bile, Exacerbates Western Diet-Induced Atherosclerosis in LDL Receptor Mutant Mice.Mol Pharmacol. 2019 Jul;96(1):47-55. doi: 10.1124/mol.119.115840. Epub 2019 May 7. Mol Pharmacol. 2019. PMID: 31064810
-
The Dynamics of Circulating Monocyte Subsets and Intra-Plaque Proliferating Macrophages during the Development of Atherosclerosis in ApoE-/- Mice.Int Heart J. 2019 May 30;60(3):746-755. doi: 10.1536/ihj.17-681. Epub 2019 Apr 25. Int Heart J. 2019. PMID: 31019169
-
Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise.Ann N Y Acad Sci. 2016 Jan;1363(1):138-54. doi: 10.1111/nyas.13009. Epub 2016 Feb 5. Ann N Y Acad Sci. 2016. PMID: 26849408 Free PMC article. Review.
-
PCSK9 and atherosclerosis: Looking beyond LDL regulation.Eur J Clin Invest. 2021 Apr;51(4):e13459. doi: 10.1111/eci.13459. Epub 2020 Dec 3. Eur J Clin Invest. 2021. PMID: 33236356 Review.
Cited by
-
High-Fat Diet, Epigenetics, and Atherosclerosis: A Narrative Review.Nutrients. 2024 Dec 31;17(1):127. doi: 10.3390/nu17010127. Nutrients. 2024. PMID: 39796562 Free PMC article. Review.
-
Causal Relationship Between Serum Uric Acid and Atherosclerotic Disease: A Mendelian Randomization and Transcriptomic Analysis.Biomedicines. 2025 Jul 28;13(8):1838. doi: 10.3390/biomedicines13081838. Biomedicines. 2025. PMID: 40868093 Free PMC article.
-
Omics-based Approach Towards Macrophages: New Perspectives of Biology and Function in the Normal and Diseased Heart.Int J Biol Sci. 2025 May 27;21(8):3666-3688. doi: 10.7150/ijbs.112061. eCollection 2025. Int J Biol Sci. 2025. PMID: 40520014 Free PMC article. Review.
-
Metabolic and Immune Crosstalk in Cardiovascular Disease.Circ Res. 2025 May 23;136(11):1433-1453. doi: 10.1161/CIRCRESAHA.125.325496. Epub 2025 May 22. Circ Res. 2025. PMID: 40403115 Review.
-
Targeted drug delivery systems for atherosclerosis.J Nanobiotechnology. 2025 Apr 23;23(1):306. doi: 10.1186/s12951-025-03384-0. J Nanobiotechnology. 2025. PMID: 40269931 Free PMC article. Review.
References
-
- Domanski, M. J. et al. Time course of LDL cholesterol exposure and cardiovascular disease event risk. J. Am. Coll. Cardiol.76, 1507–1516 (2020). - PubMed
-
- Kim, M. K. et al. Associations of variability in blood pressure, glucose and cholesterol concentrations, and body mass index with mortality and cardiovascular outcomes in the general population. Circulation138, 2627–2637 (2018). - PubMed
-
- Bangalore, S. et al. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial. J. Am. Coll. Cardiol.65, 1539–1548 (2015). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous